Kucukgoz Gulec U - Search Results

1

GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor.

Eroglu EC, Kucukgoz Gulec U, Vardar MA, Paydas S. Eroglu EC, et al. Among authors: kucukgoz gulec u. Eur J Mass Spectrom (Chichester). 2022 Feb;28(1-2):12-24. doi: 10.1177/14690667221098520. Epub 2022 May 3. Eur J Mass Spectrom (Chichester). 2022. PMID: 35503418

2

Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia.

Kucukgoz Gulec U, Paydas S, Guzel AB, Buyukkurt S, Seydaoglu G, Vardar MA. Kucukgoz Gulec U, et al. Med Oncol. 2012 Dec;29(4):2937-43. doi: 10.1007/s12032-012-0165-4. Epub 2012 Jan 25. Med Oncol. 2012. PMID: 22274916

3

Mature cystic teratoma of the fallopian tube.

Khatib G, Guzel AB, Kucukgoz-Gulec U, Vardar MA, Musaev A, Melekoglu R. Khatib G, et al. Among authors: kucukgoz gulec u. J Obstet Gynaecol. 2013 Feb;33(2):120-4. doi: 10.3109/01443615.2012.731452. J Obstet Gynaecol. 2013. PMID: 23445130 Review.

4

Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.

Kucukgoz Gulec U, Gumurdulu D, Guzel AB, Paydas S, Seydaoglu G, Acikalin A, Khatib G, Zeren H, Vardar MA, Altintas A. Kucukgoz Gulec U, et al. Arch Gynecol Obstet. 2014 Feb;289(2):393-8. doi: 10.1007/s00404-013-3000-z. Epub 2013 Aug 22. Arch Gynecol Obstet. 2014. PMID: 23974278

5

The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.

Kucukgoz Gulec U, Paydas S, Guzel AB, Vardar MA, Khatib G, Gumurdulu D. Kucukgoz Gulec U, et al. Arch Gynecol Obstet. 2015 Oct;292(4):923-9. doi: 10.1007/s00404-015-3699-9. Epub 2015 Apr 9. Arch Gynecol Obstet. 2015. PMID: 25855053

6

A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer.

Khatib G, Küçükgöz Güleç Ü, Bariş Güzel A, Uygur B, Seydaoğlu G, Gümürdülü D, Vardar MA. Khatib G, et al. Among authors: kucukgoz gulec u. Int J Gynecol Cancer. 2016 Oct;26(8):1480-4. doi: 10.1097/IGC.0000000000000786. Int J Gynecol Cancer. 2016. PMID: 27465899

7

Primitive uterine neuroectodermal tumours: Two case reports.

Eskiyörük İ, Küçükgöz Güleç Ü, Paydaş S, Güzel AB, Vardar MA, Bağır E. Eskiyörük İ, et al. Among authors: kucukgoz gulec u. Turk J Obstet Gynecol. 2015 Sep;12(3):185-187. doi: 10.4274/tjod.58295. Epub 2015 Sep 15. Turk J Obstet Gynecol. 2015. PMID: 28913066 Free PMC article.

8

Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.

Temur I, Kucukgoz Gulec U, Paydas S, Guzel AB, Sucu M, Vardar MA. Temur I, et al. Among authors: kucukgoz gulec u. Eur J Obstet Gynecol Reprod Biol. 2018 Jul;226:25-29. doi: 10.1016/j.ejogrb.2018.05.028. Epub 2018 May 22. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29804024

9

Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.

Kucukgoz Gulec U, Kilic Bagir E, Paydas S, Guzel AB, Gumurdulu D, Vardar MA. Kucukgoz Gulec U, et al. Arch Gynecol Obstet. 2019 Aug;300(2):377-382. doi: 10.1007/s00404-019-05180-2. Epub 2019 May 10. Arch Gynecol Obstet. 2019. PMID: 31076855

10

Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma.

Kucukgoz Gulec U, Kilic Bagir E, Paydas S, Guzel AB, Gumurdulu D, Vardar MA. Kucukgoz Gulec U, et al. Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:51-55. doi: 10.1016/j.ejogrb.2019.11.006. Epub 2019 Nov 8. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31739121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page